Paper2732467
Effect of lipopolysaccharide on C3 and C5 production by human lung cells.
Rothman BL and 4 others. J Immunol, 1989. Cited by 23 papers, by iCite.
Cite this record
ConductScience Library. Effect of lipopolysaccharide on C3 and C5 production by human lung cells. Papers, record 2732467. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2732467
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Complement C3 | Major topic |
| Complement C5 | Major topic |
| Lipopolysaccharides | Major topic |
| Lung | Major topic |
| Animals | |
| Cattle | |
| Cell Line | |
| Fetal Blood | |
| Fibroblasts | |
| Humans | |
| Kinetics | |
| Protein Biosynthesis |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| HL24240 | NHLBI NIH HHS | United States | R01HL024240 | PubMed and NIH | NIH RePORTER |
| HL25015 | NHLBI NIH HHS | United States | R01HL025015 | PubMed and NIH | NIH RePORTER |
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38166725 | Vitamin D3 improved hypoxia-induced lung injury by inhibiting the complement and coagulation cascade and autophagy pathway. | BMC Pulm Med | 2024 | https://conductscience.org/library/papers/38166725 | PubMed |
| 25520716 | Preterm birth, intrauterine infection, and fetal inflammation. | Front Immunol | 2014 | https://conductscience.org/library/papers/25520716 | PubMed |
| 25017204 | Elevated expression of SLC34A2 inhibits the viability and invasion of A549 cells. | Mol Med Rep | 2014 | https://conductscience.org/library/papers/25017204 | PubMed |
| 23320021 | Role of complement in multiorgan failure. | Clin Dev Immunol | 2012 | https://conductscience.org/library/papers/23320021 | PubMed |
| 21402362 | A major role for capsule-independent phagocytosis-inhibitory mechanisms in mammalian infection by Cryptococcus neoformans. | Cell Host Microbe | 2011 | https://conductscience.org/library/papers/21402362 | PubMed |
| 19189846 | Gene profiling studies in the neonatal ovine lung show enhancing effects of VEGF on the immune response. | Dev Comp Immunol | 2009 | https://conductscience.org/library/papers/19189846 | PubMed |
| 18039838 | The opportunistic human pathogenic fungus Aspergillus fumigatus evades the host complement system. | Infect Immun | 2008 | https://conductscience.org/library/papers/18039838 | PubMed |
| 12414531 | Generation of C5a by phagocytic cells. | Am J Pathol | 2002 | https://conductscience.org/library/papers/12414531 | PubMed |
| 10770816 | Generation of complement C3 and expression of cell membrane complement inhibitory proteins by human bronchial epithelium cell line. | Thorax | 2000 | https://conductscience.org/library/papers/10770816 | PubMed |
| 9317016 | Secretion of the C3 component of complement by peritoneal cells cultured with encapsulated Cryptococcus neoformans. | Infect Immun | 1997 | https://conductscience.org/library/papers/9317016 | PubMed |
| 8344703 | C3 synthesis by A549 alveolar epithelial cells is increased by interferon-gamma and dexamethasone. | Immunology | 1993 | https://conductscience.org/library/papers/8344703 | PubMed |
| 8291606 | Effect of interleukin-4 on the synthesis of the third component of complement by pulmonary epithelial cells. | Am J Pathol | 1994 | https://conductscience.org/library/papers/8291606 | PubMed |
| 8040328 | Alveolar type II epithelial cells produce interleukin-6 in vitro and in vivo. Regulation by alveolar macrophage secretory products. | J Clin Invest | 1994 | https://conductscience.org/library/papers/8040328 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| C1R | 715 | PubTator's text mining | https://conductscience.org/library/genes/715 | NCBI Gene |
| C1S | 716 | PubTator's text mining | https://conductscience.org/library/genes/716 | NCBI Gene |
| C3 | 718 | PubTator's text mining | https://conductscience.org/library/genes/718 | NCBI Gene |
| C5 | 727 | PubTator's text mining | https://conductscience.org/library/genes/727 | NCBI Gene |
| CFH | 3075 | PubTator's text mining | https://conductscience.org/library/genes/3075 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2732467
GET https://conductscience.org/api/papers/v1/2732467/authors